Europe’s first stem cell therapy backed by NICE – PharmaTimes
|
Europe's first stem cell therapy backed by NICE
PharmaTimes Eisai's Holoclar, the first stem–cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition. The National Institute for Health and Care Excellence has now … |
